
Yewebdar T. Tadesse
Examiner (ID: 18610, Phone: (571)272-1238 , Office: P/1717 )
| Most Active Art Unit | 1717 |
| Art Unit(s) | 1734, 1713, 1717, 1792 |
| Total Applications | 1806 |
| Issued Applications | 1359 |
| Pending Applications | 126 |
| Abandoned Applications | 345 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19164755
[patent_doc_number] => 11980637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy
[patent_app_type] => utility
[patent_app_number] => 17/233802
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12146
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233802
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233802 | Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy | Apr 18, 2021 | Issued |
Array
(
[id] => 17943553
[patent_doc_number] => 20220330570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => METHOD AND SYSTEM FOR MANUFACTURING CHILL POPS
[patent_app_type] => utility
[patent_app_number] => 17/231378
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2377
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231378
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231378 | METHOD AND SYSTEM FOR MANUFACTURING CHILL POPS | Apr 14, 2021 | Abandoned |
Array
(
[id] => 17355349
[patent_doc_number] => 20220016145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND OTHER DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/222662
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222662
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/222662 | Compositions and methods for treating muscular dystrophy and other disorders | Apr 4, 2021 | Issued |
Array
(
[id] => 18232072
[patent_doc_number] => 11596614
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => Treatment of intrahepatic cholestatic diseases
[patent_app_type] => utility
[patent_app_number] => 17/221784
[patent_app_country] => US
[patent_app_date] => 2021-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4280
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221784
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/221784 | Treatment of intrahepatic cholestatic diseases | Apr 2, 2021 | Issued |
Array
(
[id] => 20301268
[patent_doc_number] => 12447238
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Antimicrobial tubular conduits
[patent_app_type] => utility
[patent_app_number] => 17/907290
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 6293
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907290
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907290 | Antimicrobial tubular conduits | Mar 25, 2021 | Issued |
Array
(
[id] => 18449452
[patent_doc_number] => 20230190728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => NEW THERAPEUTIC USES OF COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/913379
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913379 | NEW THERAPEUTIC USES OF COMPOUNDS | Mar 24, 2021 | Pending |
Array
(
[id] => 18595333
[patent_doc_number] => 20230270121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => NOVEL ORGANIC FUNGICIDE
[patent_app_type] => utility
[patent_app_number] => 18/006701
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006701
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006701 | NOVEL ORGANIC FUNGICIDE | Mar 18, 2021 | Pending |
Array
(
[id] => 18018921
[patent_doc_number] => 20220370420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => SPIROCYCLIC 2,3-DIHYDRO-7-AZAINDOLE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/204089
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 97291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204089 | Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof | Mar 16, 2021 | Issued |
Array
(
[id] => 16991765
[patent_doc_number] => 20210230185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AS MUTANT IDH1 AND IDH2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/202515
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202515
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/202515 | 7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors | Mar 15, 2021 | Issued |
Array
(
[id] => 18315087
[patent_doc_number] => 11629156
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => 7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/202867
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17155
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202867
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/202867 | 7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors | Mar 15, 2021 | Issued |
Array
(
[id] => 18383327
[patent_doc_number] => 11654091
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-05-23
[patent_title] => Hydrophobic topical lotion for swimmers to reduce friction when swimming
[patent_app_type] => utility
[patent_app_number] => 17/202061
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3049
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202061
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/202061 | Hydrophobic topical lotion for swimmers to reduce friction when swimming | Mar 14, 2021 | Issued |
Array
(
[id] => 17385494
[patent_doc_number] => 20220033346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => METHODS OF TREATING FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 17/199860
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199860
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199860 | Methods of treating fibrosis | Mar 11, 2021 | Issued |
Array
(
[id] => 16945855
[patent_doc_number] => 20210204546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => RERBICIDES
[patent_app_type] => utility
[patent_app_number] => 17/194537
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194537
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194537 | RERBICIDES | Mar 7, 2021 | Abandoned |
Array
(
[id] => 16913775
[patent_doc_number] => 20210186867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => DRUG DELIVERY SYSTEM FOR THE DELIVERY OF ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/193493
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17193493
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/193493 | DRUG DELIVERY SYSTEM FOR THE DELIVERY OF ANTIVIRAL AGENTS | Mar 4, 2021 | Abandoned |
Array
(
[id] => 17065838
[patent_doc_number] => 20210268053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => FAT ABSORPTION INHIBITING AGENT, FOOD AND DEFATTED SESAME SEEDS, AND METHOD FOR INHIBITING OBESITY
[patent_app_type] => utility
[patent_app_number] => 17/183646
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17183646
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/183646 | Fat absorption inhibiting agent, food and defatted sesame seeds, and method for inhibiting obesity | Feb 23, 2021 | Issued |
Array
(
[id] => 16898941
[patent_doc_number] => 20210177857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/183596
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17183596
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/183596 | THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING THE SAME | Feb 23, 2021 | Abandoned |
Array
(
[id] => 17035039
[patent_doc_number] => 20210251997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => PALIPERIDONE FOR TREATMENT OF DRUG REFRACTORY IRRITABILITY AND AUTISM SPECTRUM DISORDER
[patent_app_type] => utility
[patent_app_number] => 17/181716
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17181716
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/181716 | PALIPERIDONE FOR TREATMENT OF DRUG REFRACTORY IRRITABILITY AND AUTISM SPECTRUM DISORDER | Feb 21, 2021 | Abandoned |
Array
(
[id] => 17198745
[patent_doc_number] => 20210338839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY
[patent_app_type] => utility
[patent_app_number] => 17/181187
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17181187
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/181187 | COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY | Feb 21, 2021 | Abandoned |
Array
(
[id] => 17065033
[patent_doc_number] => 20210267248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => Nutritional Compositions for Treating Cancer and Side Effects of Cancer Conventional Treatments
[patent_app_type] => utility
[patent_app_number] => 17/180804
[patent_app_country] => US
[patent_app_date] => 2021-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180804
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/180804 | Nutritional Compositions for Treating Cancer and Side Effects of Cancer Conventional Treatments | Feb 20, 2021 | Abandoned |
Array
(
[id] => 17035054
[patent_doc_number] => 20210252012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
[patent_app_type] => utility
[patent_app_number] => 17/176018
[patent_app_country] => US
[patent_app_date] => 2021-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176018
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/176018 | Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity | Feb 14, 2021 | Abandoned |